NRG CC004 Skip To Content

Study ID: NRG CC004


Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women with Breast or Gynecologic Cancer

This is a trial of bupropion versus placebo for sexual desire in women with breast or gynecological cancers. The trial will be measuring the ability of two dose levels of bupropion to improve sexual desire more than a placebo at 9 weeks.
Bismarck Region, Fargo Region, Sioux Falls Region
Principal Investigator:
Preston Steen, MD;Maria Bell, MD,Preston Steen, MD,Preston Steen, MD
Cancer Control, Breast - Invasive, Endometrial, Gynecologic, Other, Ovary/Fallopian Tube/Primary Peritoneal, Vulvar, Cervix
Phase II
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.